Concepedia

Ngoc Mai

NM

Statistics

Publications

8

Citations

291

H-Index

8

Active since

1984

Affiliations

Theravance Biopharma (United States)(Current)

Ngoc Mai is an author at Theravance Biopharma (United States) specializing in pharmacology, medicine, and molecular pharmacology.

Top concepts

Publications per year

1984–2009

8

Publications

8

The 5‐HT<sub>4</sub> receptor agonist, tegaserod, is a potent 5‐HT<sub>2B</sub> receptor antagonist <i>in vitro</i> and <i>in vivo</i>

David T. Beattie, Jacqueline A.M. Smith, Daniel G. Marquess et al. · British Journal of Pharmacology · 2004 · 119 citations · Full text

The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone

David T. Beattie, Madhavi Cheruvu, Ngoc Mai et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2007 · 34 citations

, , +9

Comparison of the Pharmacological Properties of Rat Na<sub>V</sub>1.8 with Rat Na<sub>V</sub>1.2a and Human Na<sub>V</sub>1.5 Voltage-Gated Sodium Channel Subtypes Using a Membrane Potential Sensitive Dye and FLIPR<sup>R</sup>

R. Vickery, Shanti M. Amagasu, Ray Chang et al. · Receptors and Channels · 2004 · 33 citations

, , +17

Influence of ligand binding kinetics on functional inhibition of human recombinant serotonin and norepinephrine transporters

Pamela R. Tsuruda, Joey Yung, William J. Martin et al. · Journal of Pharmacological and Toxicological Methods · 2009 · 32 citations

, , +6

Comparison of the Pharmacological Properties of Rat NaV1.8 with Rat NaV1.2a and Human NaV1.5 Voltage-Gated Sodium Channel Subtypes Using a Membrane Potential Sensitive Dye and FLIPRR

R. Vickery, Shanti M. Amagasu, Ray Chang et al. · Receptors and Channels · 2004 · 24 citations

, , +24

1–5 of 8